Yared Hailemichael PhD

Yared Hailemichael, PhD is a research instructor at MD Anderson Cancer Center. He and his colleagues have made seminal contributions to cancer immunology in defining the regulation of CD8+ cytotoxic T cell tumor localization and tumor killing, leading to a Phase I clinical study of novel vaccine. In his major contribution to cancer immunotherapy, he showed persistent cancer vaccine formulations force tumor-specific T cells sequestration, dysfunction and deletion at the vaccination site, preventing them from trafficking to tumor and cause tumor destruction.